Arsenals Cultural Reach Brand Strength Amid OnField Challenges US Private Payrolls Rise 109000 in April Exceeding Expectations ADP Report Fed Officials Signal Potential Rate Hike If Inflation Remains Elevated Meeting Minutes Reveal Caribbean Islanders Raise Concerns Over Foreign Developer Land Acquisitions Restricting Beach Access Latin American Leaders at WUF13 Call for New Housing Finance Models and ClimateResilient Urban Development Chinas Worst Mining Disaster in Over a Decade Claims 82 Lives at Liushenyu Mine Implications for Coal Sector Safety TBH Q4 2025 Earnings Massive EPS Miss Overshadowed by Stock Surge RRC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency and Cost Controls Booz Allen Hamilton Q1 2026 Earnings EPS Crushes Estimates as Government Contractor Delivers Strong Operational Results MBINL Q1 2026 Earnings EPS Surpasses Estimates Preferred Shares Edge Higher FTHM Q4 2025 Earnings EPS Misses Estimates as Losses Widen Stock Edges Higher WHLRD Q2 2024 Earnings Preferred Dividend Coverage Remains Robust Amid Limited Market Visibility RTX Corporation RTX Edges Higher Approaches Key Resistance Level Crocs Inc CROX Holds Steady Near Midpoint as Footwear Sector Watches for Breakout Bitfarms BITF Remains Flat at 198 as Key Levels Frame a Tight Trading Range Public Storage PSA Holds Steady Near 305 as Traders Eye Key Resistance Levels PLUS THERAPEUTICS Inc PSTV Holds Steady Near 660 Consolidation Signals Caution Q32 Bio Q1 2026 Earnings Narrowed Loss Exceeds Expectations Stock Rises IMMR Q3 2025 Earnings EPS Surges Past Estimates as Licensing Revenue Drives Profitability CHCT Q1 2026 Earnings Massive EPS Surprise Masks Concerns as Stock Slips UTZ Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower on Mixed Sentiment FTK Q1 2026 Earnings EPS Misses Estimates as Stock Declines Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Global Oil Reserve Drawdown Expected to Shape Energy Markets in 2026 Two Key Predictions KHC Q1 2026 Earnings EPS Surges Past Estimates Amid Cost Discipline Tarsus Pharmaceuticals TARS Sees Minor Pullback as Traders Eye Support Zone